Page 43 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

Salivary gland pleomorphic adenoma in the Netherlands
24 Micheli A, Mariotto A, Giorgi Rossi A, et al. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 1998; 34: 2271-2278
25 Gove WR, Hughes M. Possible causes of the apparent sex differences in physical health: an empirical investigation. Am Sociol Rev 1979; 44: 126-146
26 Cleary PD, Mechanic D, Greenley JR. Sex differences in medical care utilization: an empirical investigation. J Health Soc Behav 1982; 23: 106-119
27 Pietras RJ, Márquez-Garbán DC. Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res 2007; 13: 4672-4676
28 Glas AS, Hollema H, Nap RE, et al. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland. Cancer 2002; 94: 2211-2216
29 In der Maur CD, Klokman WJ, van Leeuwen FE, et al. Increased risk of breast cancer development after diagnosis of salivary gland tumour. Eur J Cancer 2005; 41: 1311-1315
30 Kelsey JL BL. Epidemiology and prevention of breast cancer. Annu Rev Public Heal 1996 1996; 17: 47- 67
31 Reeves GK, Pirie K, Green J, Bull D BVMWSC. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer 2009; 100: 538-544
32 Ewertz M, Duffy SW, Adami HO, Kvåle G, Lund E, Meirik O, Mellemgaard A, Soini I TH. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer 1990; 46: 597-603
33 Phillips P, Olsen K. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature.tle. Ann Otol Rhinol Laryngol 1995; 104: 447-452
34 Ellis DW, Srigley J. Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based datasets. Virchows Arch August 2015: 1-9
35 Antony J, Gopalan V, Smith R a., et al. Carcinoma ex Pleomorphic Adenoma: A Comprehensive Review of Clinical, Pathological and Molecular Data. Head Neck Pathol 2012; 6: 1-9
36 Wittekindt C1, Streubel K, Arnold G, Stennert E G-LO. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck 2007 Sep;29(9)822-8 2007; 29: 822-828
37 Zbären P, Tschumi I, Nuyens M, et al. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg 2005; 189: 203-207
38 McGregor a D, Burgoyne M, Tan KC. Recurrent pleomorphic salivary adenoma--the relevance of age at first presentation. Br J Plast Surg 1988; 41: 177-181
39 Renehan A, Gleave EN, McGurk M. An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. Am J Surg 1996; 172: 710-714
40 Turk AT WB. Ovid: Pitfalls in the Biopsy Diagnosis of Intraoral Minor Salivary Gland Neoplasms: Diagnostic Considerations and Recommended Approach. Adv Anat Pathol 2014 Jan;21(1)1-11 2014; 21: 1-11
41 Maran A, Mackenzie I, Stanley R. Recurrent pleomorphic adenomas of the parotid gland. Arch Otolaryngol 1984; 110: 167-171
42 Myssiorek D, Ruah C, Hybels R. Recurrent pleomorphic adenomas of the parotid gland. Head Neck 1990; 12: 332-336
43 Maxwell EL, Hall FT FJ. Recurrent pleomorphic adenoma of the parotid gland. J Otolaryngol 2004; 33: 181-184
44 Postema RJ, van Velthuysen ML, van den Brekel MW, Balm AJ PJ. Accuracy of fine-needle aspiration cytology of salivary gland lesions in the netherlands cancer institute. Head Neck 2004; 26: 418-424
2
41